Moore John R's Form 4 filing
Edgewise Therapeutics, Inc. (EWTX) · filed Sep 24, 2024
- Accession no.
- 0001562180-24-006946
- Filed
- Sep 24, 2024
- Trade date
- Sep 20-23, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.00M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moore John RCIK 0001191702 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 20, 2024 | Common Stock | MOption exerciseAcquired | +50,000 | $0.71 | +$35,500 | 53,252 | Direct | |
| Sep 20, 2024 | Common Stock | SSaleDisposed | −50,000 | $28.37 | −$1,418,500 | 3,252 | Direct | |
| Sep 23, 2024 | Common Stock | MOption exerciseAcquired | +20,922 | $0.71 | +$14,854.62 | 24,174 | Direct | |
| Sep 23, 2024 | Common Stock | SSaleDisposed | −20,922 | $27.63 | −$578,074.86 | 3,252 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 20, 2024 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 62,558 | Direct | |
| Sep 23, 2024 | Common Stock | MOption exerciseDisposed | −20,922 | $0.00 | $0 | 41,636 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.